SciELO - Scientific Electronic Library Online

vol.40 número2Datos clínicos y de laboratorio en hepatitis autoinmune pediátrica: estudio del centro de referencia en IránImpacto del COVID-19 en las enfermedades hepáticas y la salud pública en el Perú índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados




  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO


Revista de Gastroenterología del Perú

versão impressa ISSN 1022-5129


MUNOZ ZAMBRANO, María Elena et al. Serological diagnosis of Fasciola hepatica infection: a systematic review. Rev. gastroenterol. Perú [online]. 2020, vol.40, n.2, pp.155-161. ISSN 1022-5129.


Fascioliasis is a disease caused by the parasite Fasciola hepatica, according to its clinical picture, it can be classified into two phases: acute and chronic, currently the diagnosis is made during the chronic phase, however, early detection would allow to provide an effective treatment and timely.


This study is carried out with the objective of evaluating the diagnostic validity of serological tests for the timely diagnosis of hepatic fascioliasis.

Materials and methods:

a systematic search of the literature was carried out in Embase, MedLine, Cochrane Library and LILACS. Study selection was performed by pairs of reviewers, diagnostic test studies were selected using: ELISA, indirect ELISA, rapid ELISA, Fas2 ELISA, Arco2 compared to sedimentation techniques for the diagnosis of hepatic fascioliasis in adults. The studies were evaluated using the QUADAS-2 tool.


Seven studies were identified that answer the PICO question, with a total of 1,317 human serum samples, the tests reported high sensitivity and specificity, FhTA, ELISA, number of studies and participants identified, summary estimators with the corresponding confidence intervals / credibility, and the ranking of treatments.


In general, the specificity of the serological tests was slightly higher than the sensitivity, there is evidence of moderate to low quality that reports their performance, however, the quality of the evidence and the heterogeneity between the studies do not allow determining its usefulness during the acute phase of the disease. More studies are needed in this regard. The studies were clinically heterogeneous between them.

Palavras-chave : Fasciola hepática; Infection; Serology; Systematic review.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )